MAHA feels betrayed after Supreme Court ruling on Monsanto, glyphosate
Prominent activists with the “Make America Healthy Again” (MAHA) movement are raging and saying they feel betrayed after the Supreme Court sided with pesticide maker Monsanto on Thursday and said it d
Prominent activists with the “Make America Healthy Again” (MAHA) movement are raging and saying they feel betrayed after the Supreme Court sided with
Read Full Story at The Hill →Why This Matters
The Supreme Court’s decision to side with Monsanto in the glyphosate dispute underscores the deepening tension between regulatory science and legal precedent—a battle that will shape how hazardous substances are litigated for years. For advocates of the "Make America Healthy Again" movement, this ruling represents more than a legal defeat; it signals a systemic failure to prioritize public health over corporate interests, potentially emboldening further challenges to environmental and consumer protections.
Background Context
The dispute traces back to decades of conflicting research on glyphosate’s safety, with regulators like the EPA initially classifying it as non-carcinogenic before the World Health Organization’s International Agency for Research on Cancer labeled it a probable carcinogen in 2015. Meanwhile, Monsanto—now owned by Bayer—has aggressively defended its product, spending millions on litigation and lobbying to maintain its dominance in the $13 billion global herbicide market, while plaintiff lawsuits have piled up alleging harm from prolonged exposure.
What Happens Next
The ruling effectively closes one major legal avenue for glyphosate critics, but it may galvanize state-level bans and stricter local regulations, creating a patchwork of restrictions that could disrupt agribusiness supply chains. Watch for Bayer’s next moves—whether they double down on glyphosate or pivot to alternative herbicides—as well as potential federal agency reviews under renewed public pressure. Meanwhile, activists are likely to escalate direct-action campaigns targeting both corporate and political targets.
Bigger Picture
This case fits a broader pattern of industries weaponizing legal systems to shield products from scrutiny, echoing past fights over asbestos, lead, and tobacco—where scientific consensus lagged behind corporate litigation strategies. It also highlights the growing fragmentation of public trust in institutions, as grassroots movements increasingly bypass traditional regulatory channels in favor of direct advocacy or litigation, reshaping how policy and corporate accountability will be enforced in the future.
